Benign prostatic hyperplasia Trials in New York, United States
Conditions / Benign prostatic hyperplasia / New York, United States
Research into Benign prostatic hyperplasia spans multiple therapeutic approaches and trial phases.
27 total trials for this combination
Showing top 10 of 27 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01966614 | Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH | COMPLETED | PHASE3 |
| NCT00224133 | The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months | COMPLETED | PHASE3 |
| NCT01097707 | A Study in Men With Benign Prostatic Hyperplasia | TERMINATED | PHASE2 |
| NCT00237536 | Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia | TERMINATED | PHASE2 |
| NCT02326454 | A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia | COMPLETED | PHASE2 |
| NCT00848081 | A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers | COMPLETED | PHASE3 |
| NCT06511141 | Sacral Neuromodulation for Male Overactive Bladder (MOAB) | RECRUITING | — |
| NCT00827242 | Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily | COMPLETED | PHASE3 |
| NCT01939184 | Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia | COMPLETED | PHASE2 |
| NCT01294150 | The Safety and Effectiveness of UroLift: LIFT Pivotal Study | COMPLETED | NA |